Bioanalysis

BioAnalysis is a Philadelphia-based contract research organization (CRO) that provides specialized analytical and biophysical testing services for the biopharmaceutical industry. The company focuses on complex modalities, including gene therapies, monoclonal antibodies, and antibody-drug conjugates, utilizing advanced techniques such as mass spectrometry and analytical ultracentrifugation (AUC). BioAnalysis is recognized for its expertise in characterizing viral vectors and assessing critical quality attributes (CQAs) to support drug development from discovery through commercialization. Founded in 2019, the company operates a cGMP-compliant facility and emphasizes a collaborative, science-driven approach to client partnerships.